Novo Nordisk Strikes $2B Deal for Obesity Drug
Novo Nordisk has signed an exclusive global licensing deal worth up to $2 billion for UBT251, a weight-loss drug developed by ...
pharmaphorum15d
Novo Nordisk pledges $4.1bn for US injectables plant
The new plant will be one of the largest manufacturing investments in Novo Nordisk’s history and will add 1.4 million sq ft of production space for aseptic manufacturing and finished production ...
FoodNavigator4h
Outcry as Novo Nordisk Foundation looks at UPF classification
It stressed that while the funding came from the Novo Nordisk Foundation, the project itself would be carried out by ...
Software maker SAP unseats Novo Nordisk as Europe's largest company
German software company SAP overtook Danish healthcare company Novo Nordisk as Europe's largest company by market ...
The United Laboratories and Novo Nordisk announce exclusive license agreement for UBT251, a GLP-1/GIP/glucagon triple receptor agonist
The issuer is solely responsible for the content of this announcement.
Yahoo Finance11d
Pioneering plant microbiome research: Julia Vorholt receives 2025 Novonesis Biotechnology Prize from the Novo Nordisk Foundation
Her innovative research on plant microbiomes holds the potential ... her the 2025 Novonesis Biotechnology Prize, awarded by the Novo Nordisk Foundation. "Receiving this prize is a tremendous ...
TMCnet11d
Pioneering plant microbiome research: Julia Vorholt receives 2025 Novonesis Biotechnology Prize from the Novo Nordisk Foundation
But how do these microbial communities work? And can we harness their power to make agriculture more sustainable? These ...
Finanznachrichten11d
Pioneering plant microbiome research: Julia Vorholt receives 2025 Novonesis Biotechnology Prize from the Novo Nordisk Foundation
COPENHAGEN, Denmark, March 13, 2025 /PRNewswire/ -- Professor Julia Vorholt's work has changed how we think about plant health. Her innovative research on plant microbiomes holds the potential to ...